Medication-Assisted Treatment for Co-Occurring Disorders: What Middlesex County Residents Need to Know

When someone in Kendall Park or South Brunswick is struggling with both a substance use disorder and a mental health condition — depression, anxiety, PTSD, bipolar disorder — getting the right treatment is complicated. One question families ask repeatedly: does medication-assisted treatment (MAT) actually work, and is it appropriate when mental health is part of the picture?

The short answer is yes. MAT is an evidence-based approach that combines FDA-approved medications with counseling and behavioral therapies. It is not a shortcut or a substitute for real recovery. For many New Jersey residents managing co-occurring disorders, it is the component of treatment that makes everything else possible. This article explains what MAT is, how it works, when it is appropriate, and how Middlesex County residents can access it.

What Medication-Assisted Treatment Actually Is

MAT uses specific medications, approved by the Food and Drug Administration, to reduce the physical and psychological burden of substance use disorders — particularly opioid use disorder and alcohol use disorder — so that the rest of treatment can work.

The most commonly used MAT medications include:

• Buprenorphine (for example Suboxone; also a monthly injection, Sublocade): A partial opioid agonist that reduces cravings and withdrawal symptoms without producing the high of full opioids. Since 2023, any clinician with a standard DEA registration, including many primary care doctors, can prescribe it.
• Methadone: A long-acting opioid agonist dispensed through certified opioid treatment programs (OTPs). Visits are frequent at first; take-home doses are allowed as treatment stabilizes. It is a first-line option, not a last resort.
• Naltrexone (oral tablets, or Vivitrol monthly injection): An opioid antagonist that blocks the euphoric effects of opioids and alcohol. No abuse potential. Requires 7 to 10 days without opioids before starting. After a missed or stopped dose, tolerance is lower and overdose risk is higher.
• Naloxone: Primarily used for overdose reversal but also included in combination medications like Suboxone to deter misuse.
• Acamprosate and disulfiram: Used for alcohol use disorder. Acamprosate helps people who have already stopped drinking stay stopped (the dose is lowered for reduced kidney function, and it is not used with severe kidney disease); disulfiram creates an aversive reaction to alcohol consumption.

These are not interchangeable. The right medication depends on the substance involved, the individual's medical history, and what other psychiatric medications they may already be taking — which is why co-occurring mental health conditions require careful clinical coordination.

Why Co-Occurring Disorders Change the MAT Conversation

Co-occurring mental health conditions are common: among U.S. adults aged 18–64 with OUD in 2015–2017, 64.3% had a past-year mental illness and 26.9% serious mental illness (NSDUH; Jones and McCance-Katz, 2019).

The clinical term is "co-occurring disorders" or "dual diagnosis." Common combinations include:

• Opioid use disorder + depression or anxiety
• Alcohol use disorder + PTSD
• Stimulant use disorder + bipolar disorder
• Cannabis use disorder + psychosis or schizophrenia spectrum disorders

Clinical guidelines recommend treating both conditions at the same time. Someone who gets their opioid use disorder stabilized on buprenorphine but receives no treatment for underlying PTSD is at high risk of relapse — or of switching to a different substance or behavior to manage the same pain. Someone whose depression is treated with antidepressants but whose alcohol use continues will see limited psychiatric benefit because alcohol is a CNS depressant that directly undermines the medication's effect.

MAT, when integrated into a comprehensive dual-diagnosis treatment plan, addresses the physical stabilization piece so that psychiatric treatment can actually reach the person. That is not a small thing. Active withdrawal — the sweating, the insomnia, the bone-deep physical craving — makes it nearly impossible to engage in therapy, process trauma, or build coping skills. MAT removes that barrier.

What the Research Shows

The strongest evidence is for opioid use disorder, where medication is recommended as first-line treatment by SAMHSA and the American Society of Addiction Medicine. Evidence for alcohol use disorder medications is also well established, though the effect sizes are smaller.

For opioid use disorder, buprenorphine and methadone reduce illicit opioid use, decrease overdose deaths, lower rates of infectious disease transmission (HIV, hepatitis C), and improve treatment retention. The Substance Abuse and Mental Health Services Administration (SAMHSA) and the American Society of Addiction Medicine (ASAM) both recommend MAT as a first-line treatment.

For alcohol use disorder, naltrexone reduces the frequency of heavy drinking days and the likelihood of relapse after a period of abstinence. Acamprosate helps people who have already stopped drinking maintain abstinence.

Research comparing integrated programs with separate care has been mixed, so ask how a program coordinates both.

One clarification that matters for families: MAT is not simply trading one addiction for another. Physical dependence on a medication and addiction are not the same thing. Someone stabilized on buprenorphine who takes it as prescribed, attends therapy, and rebuilds their life is not "still using" in any clinically meaningful sense. That framing causes people to refuse effective treatment and costs lives.

Levels of Care and How MAT Fits In

MAT is not limited to any single level of care. Depending on the severity of the substance use disorder, the psychiatric complexity, and the person's living situation and support system, MAT can be delivered across the continuum:

Medically Supervised Withdrawal (Detox): For alcohol or sedative dependence, medically supervised withdrawal is often the first step. For opioids, many people start buprenorphine or methadone directly, without a separate detox stay. Medications are used here to manage acute withdrawal safely. This is a medical service, not a treatment program — it stabilizes the body but does not address the underlying disorder.

Residential Treatment: Longer-term residential settings for people with complex co-occurring disorders can incorporate MAT alongside intensive psychiatric care and behavioral therapy. Residents receive medication management, individual and group therapy, and structured daily programming in a 24-hour clinical environment.

Partial Hospitalization Program (PHP): PHP runs five to six hours per day, five days per week, and can support MAT while the person lives at home or in a sober living environment. This level is appropriate for people who are clinically stable but need intensive daily support.

Intensive Outpatient Program (IOP): IOP runs roughly nine to twelve hours per week in multiple sessions. MAT medications can be managed through the program's prescribing clinician or coordinated with a primary care provider or psychiatrist.

Outpatient: Standard outpatient, including individual therapy and psychiatric medication management, is the ongoing maintenance level for many people stable on MAT. In New Jersey, federally qualified health centers (FQHCs) can provide buprenorphine, and certified opioid treatment programs provide both buprenorphine and methadone; methadone for opioid use disorder is dispensed only through those programs.

For Middlesex County residents, the appropriate level of care depends on clinical assessment — not on how "bad" someone thinks their situation is. A formal assessment by a licensed clinician is the right starting point.

Common Questions and Concerns

Will MAT interact with my psychiatric medication? Potentially, yes. This is why integrated prescribing — or at minimum close communication between the prescribing psychiatrist and the MAT provider — matters. Certain combinations require monitoring. This is a clinical conversation, not a reason to avoid MAT.

How long does MAT last? There is no universal timeline. The ASAM National Practice Guideline sets no limit on how long treatment should last; duration is a clinical decision, not an arbitrary cutoff. Some people remain on maintenance medications for years. Others taper off under medical supervision after a period of stability. Decisions about tapering should be made collaboratively with a prescribing clinician — not driven by stigma or insurance pressure.

Is MAT covered by insurance in New Jersey? For health plans regulated by New Jersey, state law (P.L.2017, c.28) requires coverage of medically necessary substance use treatment, including MAT, without prior authorization for the first 180 days in network. Self-funded employer plans follow federal parity rules instead; call the number on your card to confirm. Medicaid (NJ FamilyCare) covers MAT. If someone is underinsured or uninsured, the New Jersey Division of Mental Health and Addiction Services funds programs with sliding-scale or no-cost options.

My family member refuses MAT because they think it's "cheating." What do I do? Stigma around MAT is real and costs lives. The conversation is worth having directly: the goal of treatment is a stable, functional life, not a particular method of getting there. If someone is open to speaking with a clinician, a behavioral health navigator can help facilitate that conversation.

How to Access Help in Middlesex County, New Jersey

If you or someone you know in Kendall Park, South Brunswick, or elsewhere in Middlesex County is managing a substance use disorder, a mental health condition, or both, these resources connect to care:

NJMentalHealthCares: Call 866-202-4357 — a free information and referral service operated by the Mental Health Association in New Jersey and funded by the NJ Department of Human Services. Navigators help callers identify appropriate treatment options and local providers.

Middlesex County Behavioral Health Navigators: Call 732-745-3810 — county-based navigators who help residents find mental health and substance use treatment and connect to community supports.

988 Suicide & Crisis Lifeline: Call or text 988 — available 24 hours a day, seven days a week. For anyone in crisis — whether the crisis involves suicidal ideation, acute psychiatric symptoms, or a substance-related emergency — 988 connects to trained counselors who can help.

If you are in immediate danger or witnessing an overdose, call 911. Naloxone (Narcan) is available without a prescription at New Jersey pharmacies and can reverse an opioid overdose while emergency services are in transit.

The decision to seek treatment is not easy. The clinical tools available — including MAT — are effective. Middlesex County residents do not have to navigate this alone.